Stay updated on Immunotherapy Combination in Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combination in Solid Cancers Clinical Trial page.

Latest updates to the Immunotherapy Combination in Solid Cancers Clinical Trial page
- Check5 days agoChange DetectedAdded a note stating that publications are automatically filled from PubMed and may not all be about the study, replacing the previous PubMed-derived description. Updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page's government funding/operating status notice has been removed, leaving the study details and other content unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedResults data were added to the study record with Results First Submitted on 2025-08-08 and Results First Posted on 2025-08-29, and the Outcome Measures section was expanded to include adverse events, objective response rate, duration of response, progression-free survival, and PK/PD parameters.SummaryDifference0.3%

- Check55 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

- Check62 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page adds a detailed, up-to-date results-reporting section (dates, definitions, and endpoints) for safety, efficacy, and pharmacokinetics, while removing several older, broader metrics. This signals moved-forward, finalized trial results emphasis.SummaryDifference75%

Stay in the know with updates to Immunotherapy Combination in Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combination in Solid Cancers Clinical Trial page.